• Prof. Zvia Agur, Chief Scientific Officer – Founder and Chair of Optimata, PhD, a renowned scientist and one of the pioneers in the field of biomathematics. Her major scientific contributions are in the fields of cancer and other immune-related disease dynamics, as well as chemotherapy, biologic drug therapy and immunotherapy optimization. 

  • Mr. Eldad Taub, CEO – Entrepreneurial and leadership experience in complex fields which require bridging of market needs and new technology, wide multidisciplinary technology (MSc), business development and sales background.

  • Mr. Michael Agur, CFO – Optimata’s co-founder;  has extensive business and finance experience (BA in Economics, MA in Security and Diplomacy); held top executive positions in Israel’s Civil Service.

  • Mr. Yuri Kogan, Chief Mathematician – Interdisciplinary mathematician (BSc); extensive  experience in the development and implementation of biomathematical and machine learning prediction algorithms, and the integration of large datasets of patient information.

  • Dr. Moran Elishmereni, Chief Biologist – PhD in the field of Immuno-pharmacology; significant experience in leading projects which involve  creation of mathematical/statistical oncology treatment models, based on the integration of large and complex patient data bases.

  • Dr. Marina Kleiman, Chief Clinical Operations – DSc, PhD in the field of Biochemistry, Theoretical Medicine and Pharmacology, widely experienced in the various aspects of clinical trials as well as collaborations with pharma companies and medical institutions.

  • Dr. Yafit Stark, Consultant for Clinical and Regulatory – PhD, Vice President Global Clinical Development at Teva Pharmaceutical; was in charge of the clinical development of Teva Brand Products such as Copaxone , Azilect and others.